s-disease

Documents about s-disease

• Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD#181675ClinicalTrials.gov
• Minor neuropsychological deficits and stage 2 of Alzheimer's disease.#185795NCBI PubMed Central
• Path integration in Alzheimer’s disease: orientation, movement and theta rhythmicity#196163PMC Full-Text (OAI)
• Continuum of Core 1 biomarkers in preclinical Alzheimer's disease.#242159NCBI PubMed Central
• Data Management and Sharing Plan for: Cellular biomarkers for pediatric Crohn's disease#278285UNC Dataverse Dataverse OAI Archive
• Computer Vision-Based Assessment of Finger Tapping in Parkinson’s Disease#285952Repositorio Institucional de la Universidad de Burgos (RIUBU)
• MALDI mass spectrometry imaging (MSI) reveals molecular and structural heterogeneity of amyloid-β in sporadic Alzheimer's disease and Down syndrome#5545Europe PMC
• Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts.#241549Apollo
• Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson’s disease: insights from the French National Healthcare Data System (2015–2021)#246792HAL (France)
• Label-free paper-based electrochemical aptasensor with tunable selectivity for assessing neurotransmitter imbalance in Alzheimer's disease.#165491NCBI PubMed Central
• Nailfold Capillaroscopy#215460IRIS
• Age, emotional burden and deep brain stimulation electrode location shape Parkinson's disease quality of life#268320Europe PMC
• Series 3: From Infection to Disease: A Global Scoping Review of Medical and Behavioural Determinants of Progression from TB Infection to TB Disease.#140602NCBI PubMed Central
• CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study#202760IRIS
• A Multidisciplinary Perspective on Research Participation in the Era of Post-Amyloid Disclosure and Disease-Modifying Therapies#289552OSF
• Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model#184965Dipòsit Digital de la Universitat de Barcelona
• HIF-1α downregulates the APP protein after oxygen and glucose deprivation in the APPswe/PSEN1 mouse model of Alzheimer’s disease#205302e-cienciaDatos Dataverse OAI Archive
• The Hopkins Symptom Checklist (SCL-90-R): A Patient-Reported Outcome Measure in Parkinson's Disease#280641IRIS
• The neural basis of prosocial effort-based decision-making in older adults at risk for Alzheimer's disease#133207bioRxiv / medRxiv
• N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease.#143081NCBI PubMed Central
• Human brain and organoid transcriptomes reveal key receptor tyrosine kinase pathways and genetic signatures in Alzheimer's disease.#159684NCBI PubMed Central
• A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning.#174566NCBI PubMed Central
• Disintegrating ipseity: a gerontological exegesis of Alzheimer's disease and relational identity in Alice Munro's fiction.#275328NCBI PubMed Central
• A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas#287555ClinicalTrials.gov
• Scrolling for science: Assessing the quality and accuracy of Crohn’s disease-related content on Instagram reels.#288940NCBI PubMed Central
• Rheumatic mitral valve disease: Comparative outcomes of repair versus replacement.#4380NCBI PubMed Central
• Spatial proteomics of Alzheimer's disease-specific human microglial states.#9213NCBI PubMed Central
• Validation of a Patient-Reported Outcome Measure in Parkinson's Disease.#13708NCBI PubMed Central
• Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later.#14806NCBI PubMed Central
• A VAE-based methodology for deep enterotyping and Parkinson's disease diagnosis#18874bioRxiv / medRxiv
• Genetic landscape of Parkinson's disease in the Personalized Parkinson Project cohort#67980bioRxiv / medRxiv
• "Death is a Disease": Cryopreservation, Neoliberalism, and Temporal Commodification in the U.S.#96296PhilArchive
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths#123231Europe PMC
• Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2#134326bioRxiv / medRxiv
• Structural Volumetric Alterations in Parkinson's Disease With Mild Cognitive Impairment.#140476NCBI PubMed Central
• Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.#152129NCBI PubMed Central
• Novel proteomics approaches to study S-acylation in biomolecular condensate regulation and disease#186574Spiral
• Stigma and social symptoms in Parkinson’s disease: A scoping review.#214172NCBI PubMed Central
• Microbial diversity modifies the impact of air pollution on pneumococcal disease risk#216660bioRxiv / medRxiv
• Stroke-induced gut microbiome dysbiosis accelerates Alzheimer's disease progression.#218977NCBI PubMed Central
• Changing COVID-19 vaccine eligibility could reshape disease burden for all#234341bioRxiv / medRxiv
• Precision pathways: optimising amyloid PET for sustainable Alzheimer's disease care.#235958NCBI PubMed Central
• Metabolic reprogramming is critical to microglial activation in Huntington's disease.#258071NCBI PubMed Central
• Time Distributed Classification of Alzheimer's Disease on MRI Scans#261133AVESIS
• AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.#262849NCBI PubMed Central
• Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effects.#263069NCBI PubMed Central
• Mitochondrial dysfunction in Alzheimer's disease: connecting pathophysiology with neuroimaging.#281151NCBI PubMed Central
• Geometric brain signatures of Alzheimer's disease progression and subtypes#282967bioRxiv / medRxiv
• Alzheimer's Disease Pathologies Affect Dopaminergic Neural Mechanisms of Memory.#284861NCBI PubMed Central
• Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.#285318NCBI PubMed Central